Tazarotene for psoriasis

How tazarotene works on plaques and nails, why it is often paired with a steroid, the pregnancy warning, and what to watch for.

Treatment snapshot

Start with the decision - not a ranked list.

  1. Name the goal
  2. Understand the option
  3. Keep the uncertainty visible
  4. Plan the review

What is tazarotene, and how does it work on psoriasis?

Tazarotene is a topical retinoid, a synthetic form of vitamin A you apply directly to a plaque. It slows down skin cells that are growing far faster than normal, which reduces thickness, decreases scale, and lessens redness and swelling. Evidence Evidence

Why this matters

  • Sources cited, not yet graded

I read the AAD and NPF pages. Both describe tazarotene as a vitamin-A-derived retinoid that slows skin cell growth. AAD adds that it reduces thick psoriasis, decreases scale, and lessens redness and swelling.

Considerations

  • Depends on you

Both sources describe the drug class, not a guaranteed result for one plaque. How completely your plaques respond depends on the strength and formulation your dermatologist chooses.

Questions for your dermatologist

  1. Which strength and formulation are you prescribing me, and why?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.
  2. Is this meant for my skin, my nails, or both?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.

Where is it used, and why is it often paired with a steroid?

Tazarotene can be used alone or combined with a topical corticosteroid. Combining the two is common: it reduces the skin irritation tazarotene alone tends to cause. It can also produce longer-lasting results and a longer remission than tazarotene by itself. On nail psoriasis, it can reduce nail thickness, treat crumbling nails, and help nails grow back normally. The label says to avoid the eyes, mouth, and mucous membranes, and not to use it on skin affected by eczema. Evidence Evidence

Why this matters

  • Sources cited, not yet graded

AAD and the FDA label agree tazarotene is often combined with a corticosteroid, which cuts irritation and extends remission. The label I read instructs avoiding eyes, mouth, and mucous membranes, and not using it on eczema-affected skin. AAD separately describes its use on nail psoriasis.

Considerations

  • Depends on you

Neither source publishes a single map of every body site to a specific product or strength. Whether combining with a steroid fits your case, and exactly where to apply or avoid it, is a call your dermatologist makes.

Questions for your dermatologist

  1. Where exactly should I apply this, and where should I avoid it?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.
  2. Would combining this with a steroid make sense for me?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.

How often do you apply it, and how long before you know if it is working?

Most people apply a thin layer once a day, usually in the evening. The FDA label describes starting at the lower 0.05% strength and moving to 0.1% only if you tolerate it and your dermatologist decides it is needed. Results vary: a few people see their plaques clear completely, but most see roughly a 50% reduction, with remission lasting up to three months for those who clear. It is normal for plaques to look very red, and generally not painful, before they start to clear. Evidence Evidence Evidence

Why this matters

  • Sources cited, not yet graded

AAD gives the roughly 50%-reduction and up-to-three-month remission figures, and describes the redness-before-clearing pattern NPF also documents. I checked the FDA label for the dosing and strength-titration instructions.

Considerations

  • Depends on you

Neither patient-education source gives a fixed number of weeks before you should expect a change. How your own plaques respond, and when to reassess, is not a fixed rule I can supply.

Questions for your dermatologist

  1. When should I expect to see a change, and when should I come back if I do not?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.
  2. Should I start at the lower strength, and how will we decide whether to increase it?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.

What are the side effects, and what should make you call your dermatologist?

The most common effects are local skin irritation - redness, peeling, dryness, itching, or a burning sensation - which is one reason it is often paired with a steroid. Tazarotene also increases sun sensitivity, so sunscreen and protective clothing belong in your routine while you use it. The FDA label says tazarotene must not be used during pregnancy because it can cause fetal harm. Anyone who could become pregnant needs a negative pregnancy test before starting and must use effective birth control while using it. Call your dermatologist about severe irritation, or anything that feels like more than the expected redness. Evidence Evidence Evidence

Why this matters

  • Sources cited, not yet graded

The FDA label states the pregnancy contraindication and testing/contraception requirement as documented fact, not a general caution. AAD and NPF both name local irritation and sun sensitivity as the common effects.

Considerations

  • Depends on you

None of these sources quantifies how often a given side effect occurs, or your own personal risk. Whether a specific reaction is expected irritation or something to stop and call about is a judgment your dermatologist makes for your case.

Questions for your dermatologist

  1. Could I become pregnant while using this, and what does that mean for treatment?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.
  2. How much redness or irritation is expected versus something I should call about?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.

What does it cost?

I could not capture a live retail price. GoodRx returned an access-blocked response to a direct check on 2026-09-08. The FDA label I read does not mention a generic version of TAZORAC cream. Tazarotene is available as cream, gel, and foam, at more than one strength, so price varies by exact product and pharmacy. Ask your pharmacy to run both the insurance price and a discount-card price for what you were actually prescribed. Evidence

Why this matters

  • Sources cited, not yet graded

The FDA label confirms the current marketed cream formulations and strengths as of the date recorded above.

Considerations

  • Depends on you

I did not check a live pharmacy price for this figure. The number here is the published one, with its date.

Questions for your dermatologist

  1. What will this specific product cost me with my insurance?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.
  2. Is a lower-cost formulation or strength available for what you are prescribing?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.

What do other people say about using it?

No reader has sent me a first-hand account of tazarotene for psoriasis yet. Until someone does, here is what the label and the studies say about living with it. Evidence

Why this matters

  • Sources cited, not yet graded

Irritation is the most common effect, often managed by pairing tazarotene with a steroid. It is normal for plaques to redden before they clear.

Considerations

  • Depends on you

No one has told me yet what using this treatment feels like day to day.

Questions for your dermatologist

  1. What have your other patients told you about using this day to day?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.

What is worth tracking while you use it?

Keep a simple, dated record: which strength and formulation you are using, which areas you are treating, and when you started. Add a same-conditions photo (same light, distance, and angle) each time. That gives you and your dermatologist something concrete to compare at your next visit, rather than relying on memory of how a plaque looked at the start. Evidence

Why this matters

  • Sources cited, not yet graded

A dated, comparable record is what lets a visit actually answer whether the product is working. That matters here especially, since expected redness can look like a flare rather than the early reaction it usually is.

Considerations

  • Depends on you

A photo log does not replace a clinical exam and cannot by itself tell you whether a strength change is needed.

Questions for your dermatologist

  1. What should I photograph or note between now and my next visit?

    Saving keeps this on your device and needs JavaScript, which is off in this browser.

Applicability check

Who was studied?

These fields show what the cited evidence reports about the people and body sites behind outcome or safety claims. “Not reported” means the reviewed source omitted the field; “Pending exact source review” means SteadySkin has not made that determination yet.

The most common effects are local skin irritation - redness, peeling, dryness, itching, or a burning sensation - which is one reason it is often paired with a steroid. Tazarotene also increases sun sensitivity, so sunscreen and protective clothing belong in your routine while you use it. The FDA label says tazarotene must not be used during pregnancy because it can cause fetal harm. Anyone who could become pregnant needs a negative pregnancy test before starting and must use effective birth control while using it. Call your dermatologist about severe irritation, or anything that feels like more than the expected redness.

Age range
Not reported
Condition subtype
Not reported
Severity or extent
Not reported
Sample size
Not reported
Geography and care setting
Two sources are patient education (AAD, NPF). One is a current US drug label (TAZORAC cream). None is a study. None reports how often a side effect occurs.
Skin tone or phototype
Not reported
Race
Not reported
Ethnicity
Not reported
Body sites
Not reported

What that means for this page: These sources describe the range of possible local side effects, the sun-sensitivity risk, and the pregnancy contraindication this drug carries. They do not quantify how often any one side effect occurs or assess an individual reader’s risk.

Evidence behind this page

Sources

Each evidence badge opens the source and its limits. The full list stays available here.

  1. National Psoriasis FoundationPatient education · Patient education, tier 5Independence not established
    Published
    SteadySkin last checked
    What this source can and cannot tell you

    Why the independence label says this: The organization provides patient education, but its editorial and funding independence for this page was not independently reviewed.

    What this source supports

    Supports that Dovonex (calcipotriene), a synthetic vitamin D3, slows skin cell growth, flattens plaques, and removes scale, and treats scalp and nail psoriasis. Supports that Vectical (calcitriol), the naturally occurring active form of vitamin D3, helps control excessive skin cell production and cannot be applied to the face, lips, or eyes. Supports that Taclonex combines calcipotriene with a steroid. Calcipotriene side effects listed: skin irritation, stinging, burning, dry skin, peeling, rash, dermatitis, and worsening of psoriasis. Calcitriol side effects: excessive calcium in urine is common. An extremely uncommon side effect is a change in calcium metabolism limits, which should stop treatment until calcium normalizes. Increased skin tumor risk from light sensitivity is also noted. Supports that Tazorac (tazarotene), a vitamin A derivative topical retinoid, slows skin cell growth. It is normal for psoriasis plaques to become very red, often intensely so but generally not painful, before clearing when using tazarotene. Tazarotene side effects include skin irritation, dry skin, and increased sun sensitivity; sunscreen and protective clothing are recommended during use.

    What it does not support

    It does not give an application frequency for calcitriol, name a percentage of people who improve, or publish pricing. It does not mention combining tazarotene with a steroid or include a pregnancy warning for tazarotene on this page.

    Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.

  2. American Academy of DermatologyPatient education · Patient education, tier 5Independent source
    Published
    SteadySkin last checked
    What this source can and cannot tell you

    What this source supports

    Supports that tazarotene, a topical retinoid (synthetic vitamin A), slows rapidly growing skin cells, reduces thick psoriasis, decreases scale, and lessens redness and swelling. Often prescribed alongside a topical corticosteroid, which reduces skin irritation and produces longer-lasting results and a longer remission than tazarotene alone. Applied once daily as a thin layer. A few patients see complete clearing; most see about a 50% reduction, with remission lasting up to three months. Common side effects are irritation (redness, peeling, dryness, itching, burning) and increased sun sensitivity. Must not be used during pregnancy because it can cause birth defects. On nail psoriasis, can reduce nail thickness, treat crumbling nails, and help restore normal nail growth.

    What it does not support

    The page does not display its own separate revision date; the date recorded here matches the same AAD psoriasis treatment section’s dated overview page checked the same day. It does not name an exact percentage-of-patients figure beyond "most," quantify how often a side effect occurs, or state a fixed number of weeks before a check-in.

    Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.

  3. DailyMed, U.S. National Library of MedicineRegulatory · Regulatory / guideline, tier 1Relevant relationship disclosed
    Published
    SteadySkin last checked
    What this source can and cannot tell you

    Why the independence label says this: The National Library of Medicine hosts DailyMed. The product company submits the label to FDA, so it is authoritative for product labeling but not independent psoriasis evidence.

    What this source supports

    Supports that TAZORAC cream 0.05% and 0.1% are indicated for topical treatment of plaque psoriasis (0.1% also for acne vulgaris). Supports the dosing: a thin layer once daily in the evening, starting at 0.05% with an increase to 0.1% only if tolerated and indicated. Supports the pregnancy contraindication - may cause fetal harm - and the requirement for a negative pregnancy test within two weeks before starting and effective contraception during use. Supports local skin reaction warnings (itching, burning, redness, peeling) and the instruction to avoid eyes, mouth, and mucous membranes and not to use on eczema-affected skin. Supports the photosensitivity warning to avoid sun, sunlamps, and weather extremes and wear sunscreen.

    What it does not support

    The label does not mention a generic version of TAZORAC cream, quantify how often a given side effect occurs, or state a retail price.

    Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.

The app currently supports vitiligo only. You can use every psoriasis guide without the app.

Evidence source

Evidence details

Review what this source supports, what it cannot establish, and any relevant relationships.